首页> Kidney international> Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.

Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Peter,Rossing

第一单位： Steno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Gentofte, Denmark.

作者： Peter,Rossing ^[1] ; Geoffrey A,Block ^[2] ; Melanie P,Chin ^[2] ; Angie,Goldsberry ^[2] ; Hiddo J L,Heerspink ^[3] ; Peter A,McCullough ^[4] ; Colin J,Meyer ^[2] ; David,Packham ^[5] ; Pablo E,Pergola ^[6] ; Bruce,Spinowitz ^[7] ; Stuart M,Sprague ^[8] ; David G,Warnock ^[9] ; Glenn M,Chertow ^[10]

作者单位： Steno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Gentofte, Denmark. ^[1] Department of Product Development, Reata Pharmaceuticals, Irving, Texas, USA. ^[2] Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. ^[3] Baylor Scott & White Heart and Vascular Hospital, Dallas, Texas, USA. ^[4] Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. ^[5] Renal Associates PA, San Antonio, Texas; USA. ^[6] Department of Medicine, New York Presbyterian Queens, Flushing, New York, USA. ^[7] Department of Medicine, Northshore Medical University Health System-University of Chicago, Evanston, Illinois, USA. ^[8] Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA. ^[9] Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA. Electronic address: gchertow@stanford.edu. ^[10]

关键词 albuminuria chronic kidney disease diabetic nephropathy oxidative stress